Alpha Cognition Receives Japanese Patent for Alzheimer’s Disease Drug Alpha-1062, Further Strengthening Patent Portfolio
- Wednesday, December 9, 2020, 7:12
- Environment
- Add a comment
VANCOUVER, BC, Dec. 9, 2020 /PRNewswire/ — Alpha Cognition, Inc. (“ACI”), a biotherapeutics drug developer with near term commercialization potential for its Alpha-1062 Alzheimer’s drug, is pleased to announce an additional patent was recently granted in Japan for the treatment of…
About the Author
adminasapcorp has written 41806 stories on this site.